CCCC Past Earnings image   This CCCC past earnings page last updated 5/23/2022
CCCC Past Earnings
PeriodPast Earnings DateGAAP
Q1 20225/5/2022-0.650
Q4 20212/24/2022-0.310
Q3 202111/10/2021-0.510
Q2 20218/11/2021-0.510
Q1 20215/13/2021-0.490
Q4 20203/11/2021-3.450
Q3 202011/12/2020-17.550
CCCC Past Revenue
PeriodPast Earnings DateGAAP
Q1 20225/5/20220.01B
Q4 20212/24/20220.02B
Q3 202111/10/20210.01B
Q2 20218/11/20210.01B
Q1 20215/13/20210.01B
Q4 20203/11/20210.01B
Q3 202011/12/20200.01B
Quotes delayed 20 minutes

Email EnvelopeFree CCCC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
C4 Therapeutics (CCCC) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CCEL Historical Earnings
CCRN Historical Earnings
CCXI Historical Earnings
CDAK Historical Earnings
CDMO Historical Earnings
CDNA Historical Earnings
CDRE Historical Earnings
CDTX Historical Earnings
CDXC Historical Earnings
CELC Historical Earnings

CCCC Past Earnings Q&A

What was the best and worst CCCC past earnings results?
For C4 Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest CCCC past earnings result in our data set was -0.310/share posted in Q4 2021, while the lowest was in Q3 2020 when CCCC posted -17.550/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2021 when CCCC reported 0.02B in revenue, while the quarter with the lowest revenue in our data set was Q1 2021 at 0.01B of revenue.

  Suggested answer: There are 7 CCCC past earnings results in our data set.

On this page we presented the CCCC past earnings date information for C4 Therapeutics. Reviewing that CCCC Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2021, when CCCC posted gaap of -0.310/share. Meanwhile the lowest CCCC past earnings result was in Q3 2020, when CCCC posted gaap of -17.550/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2021 when CCCC reported 0.02B in revenue, while the smallest revenue quarter was Q1 2021 when CCCC reported 0.01B in revenue.

Any self directed investor doing their due diligence on CCCC or any other given stock can benefit from researching all of the C4 Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate C4 Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CCCC. Thanks for visiting, and the next time you need to research CCCC past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: GLAD Options Chain, WW Historical Stock Prices, HRTX Insider Buying.

 

CCCC Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.